# Combined Injectable Treatment for HIV and OUD

> **NCT05991622** · PHASE2 · WITHDRAWN · sponsor: **Rhode Island Hospital**

## Conditions studied

- Human Immunodeficiency Virus
- Opioid Use Disorder

## Interventions

- **DRUG:** Combined LAI Treatment: Cabenuva and Sublocade

## Key facts

- **NCT ID:** NCT05991622
- **Lead sponsor:** Rhode Island Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-04-01
- **Primary completion:** 2025-08-27
- **Final completion:** 2026-02-13
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was initiated but no participants were enrolled.
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05991622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05991622, "Combined Injectable Treatment for HIV and OUD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05991622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*